AEPMS grants marketing authorisation for ZIM Laboratories’ innovative product ‘Sildenafil’

12 May 2022 Evaluate

AEPMS - The Spanish Agency for Medicine and Healthcare Products has granted Marketing Authorisation for ZIM Laboratories’ innovative product ‘Sildenafil 50 mg’ ODS in Spain to its wholly owned European Subsidiary - SIA ZIM Laboratories.

ZIM Labs is a pioneer in developing Oral Thin Films (OTF) an innovative and novel drug delivery dosage form. The said product is developed using patented Thinoral technology, which yields instantly wettable, rapidly dissolving, and stable orally dissolving films.

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develops generic pharmaceutical products.

Zim Laboratories Share Price

109.75 -1.35 (-1.22%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.